MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$114,493K
Net Income
$45,328K
Net Profit Margin
39.59%
EPS
$0.19
Unit: Thousand (K) dollars
Revenue Breakdown
    • ASCENIV
    • BIVIGAM
    • Intermediates And Other
    • Others
Revenue Breakdown
    • Operating Segments
    • Revenue From Contract With Custo...
    • Material Reconciling Items
Revenue Breakdown
    • ADMABio Manufacturing Segment
    • Plasma Collection Centers Segmen...
    • Material Reconciling Items

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
114,493 139,163 134,224 121,984
Cost of product revenue
33,743 50,348 58,598 54,757
Gross profit
80,750 88,815 75,626 67,227
Research and development
2,597 1,377 1,528 1,031
Plasma center operating expenses
1,062 1,126 1,272 1,152
Amortization of intangible assets
55 49 38 32
Gain on sale of plasma centers
7,980 NaN NaN NaN
Selling, general and administrative
26,742 23,511 21,776 22,214
Total operating expenses
22,476 26,063 24,614 24,429
Income from operations
58,274 62,752 51,012 42,798
Interest income
NaN 487 376 400
Interest and other income
1,093 NaN NaN NaN
Interest expense
2,100 1,626 1,675 1,834
Gain on extinguishment of debt
NaN 0 -2,177 -1,159
Other expense
-140 -19 -21 -108
Other income (expense), net
-1,147 -1,158 -3,497 -2,701
Income before income taxes
57,127 61,594 47,515 40,097
Provision for income taxes
11,799 12,215 11,087 5,878
Net income
45,328 49,379 36,428 34,219
Basic EPS
0.19 0.21 0.15 0.14
Diluted EPS
0.19 0.204 0.15 0.14
Basic Average Shares
236,072,751 235,326,927 238,602,978 241,490,715
Diluted Average Shares
239,955,762 241,669,487 244,664,263 248,608,460
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

ASCENIV$97,486K BIVIGAM$15,422K Intermediates And Other$833K ADMABio ManufacturingSegment$113,741K Plasma CollectionCenters Segment$716K Material ReconcilingItems$36K (0.00%↑ Y/Y)Revenues$114,493K (-0.27%↓ Y/Y)Gross profit$80,750K (32.17%↑ Y/Y)Cost of productrevenue$33,743K (-37.17%↓ Y/Y)Income from operations$58,274K (67.07%↑ Y/Y)Total operatingexpenses$22,476K (-14.27%↓ Y/Y)Gain on sale of plasmacenters$7,980K Income before incometaxes$57,127K (70.78%↑ Y/Y)Other income(expense), net-$1,147K (19.85%↑ Y/Y)Interest and other income$1,093K Selling, general andadministrative$26,742K (11.06%↑ Y/Y)Research and development$2,597K (214.41%↑ Y/Y)Plasma centeroperating expenses$1,062K (-17.42%↓ Y/Y)Amortization of intangibleassets$55K (120.00%↑ Y/Y)Net income$45,328K (68.48%↑ Y/Y)Provision for income taxes$11,799K (80.25%↑ Y/Y)Interest expense$2,100K (6.33%↑ Y/Y)Other expense-$140K (-118.75%↓ Y/Y)

ADMA logo-svg

ADMA BIOLOGICS, INC. (ADMA)

ADMA logo-svg

ADMA BIOLOGICS, INC. (ADMA)